| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
2B4 and CD48: A powerful couple of the immune system
|
Pahima, Hadas
|
|
2019
|
204 |
C |
p. 64-68
|
article
|
| 2 |
2B4 (CD244, SLAMF4) and CS1 (CD319, SLAMF7) in systemic lupus erythematosus and cancer
|
Malaer, Joseph D.
|
|
2019
|
204 |
C |
p. 50-56
|
article
|
| 3 |
2B4 dysfunction in XLP1 NK cells: More than inability to control EBV infection
|
Pende, Daniela
|
|
2019
|
204 |
C |
p. 31-36
|
article
|
| 4 |
CD84 cell surface signaling molecule: An emerging biomarker and target for cancer and autoimmune disorders
|
Cuenca, Marta
|
|
2019
|
204 |
C |
p. 43-49
|
article
|
| 5 |
Editorial Board
|
|
|
2019
|
204 |
C |
p. ii
|
article
|
| 6 |
Signaling lymphocyte activation molecule family in systemic lupus erythematosus
|
Comte, Denis
|
|
2019
|
204 |
C |
p. 57-63
|
article
|
| 7 |
SLAM family receptors in natural killer cells – Mediators of adhesion, activation and inhibition via cis and trans interactions
|
Claus, Maren
|
|
2019
|
204 |
C |
p. 37-42
|
article
|
| 8 |
SLAMF1/CD150 in hematologic malignancies: Silent marker or active player?
|
Gordiienko, Inna
|
|
2019
|
204 |
C |
p. 14-22
|
article
|
| 9 |
SLAMF6 in health and disease: Implications for therapeutic targeting
|
Yigit, Burcu
|
|
2019
|
204 |
C |
p. 3-13
|
article
|
| 10 |
SLAMF receptors and disease
|
|
|
2019
|
204 |
C |
p. 1-2
|
article
|
| 11 |
SLAMF receptors on normal and malignant B cells
|
Shachar, Idit
|
|
2019
|
204 |
C |
p. 23-30
|
article
|
| 12 |
The role of surface molecule CD229 in Multiple Myeloma
|
Olson, Michael
|
|
2019
|
204 |
C |
p. 69-73
|
article
|
Journal description